Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01612858 · ClinicalTrials.gov registry record · Phase 4
Metabolic Abnormalities in HIV-infected Persons
A Phase 4 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01612858 is a Phase 4 study that has completed, run by Tufts Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT01612858, a Phase 4 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the relationship between insulin resistance and changes in body fat distribution in HIV-infected persons. This study measures insulin sensitivity, abdominal fat, and intramuscular fat in HIV-infected persons and examines the effect of an anti-diabetic drug (metformin or pioglitazone) on insulin sensitivity and body fat in this population.
Interventions
- DRUG Metformin
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01612858
The ClinicalTrials.gov registry entry for NCT01612858 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT01612858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01612858 about?
NCT01612858 is a clinical study titled "Metabolic Abnormalities in HIV-infected Persons". The purpose of this study is to examine the relationship between insulin resistance and changes in body fat distribution in HIV-infected persons. This study measures insulin sensitivity, abdominal fat, and intramuscular fat in HIV-infected persons and examines the effect of an anti-diabetic drug (me...
What is the current status of trial NCT01612858?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2011-06. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01612858?
The interventions under investigation include: Metformin (DRUG), Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT01612858?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.